Figure S1
). We randomly selected 90% of all the samples and performed statistical tests for each different type of association. For the age effect on immune traits we used the Spearman correlation; for the gender effect on immune traits we used a t-test; and for the seasonal effect on immune traits we used a cosinor model. We repeated this 100 times and show the statistical significance for each test (-log10 P value) using gradient colour. In each panel, the rows represent the immune traits, and the columns represent each individual resampling. We counted the number of traits that show consistent results when compared with the original full dataset in more than 70% of the sampling. In this way we could reproduce 91% of all the immune traits of the age effects, 87% of the gender effects and 94% of the seasonal effects. Recombination rate (cM/Mb) Figure 3) . We randomly selected 90% of all the samples and performed statistical tests for each different type of association. For the age effect on immune traits we used the Spearman correlation; for the gender effect on immune traits we used a t-test; and for the seasonal effect on immune traits we used a cosinor model. We repeated this 100 times and show the statistical significance for each test (-log10 P value) using gradient colour. In each panel, the rows represent the immune traits, and the columns represent each individual resampling. We counted the number of traits that show consistent results when compared with the original full dataset in more than 70% of the sampling. In this way we could reproduce 91% of all the immune traits of the age effects, 87% of the gender effects and 94% of the seasonal effects. Tables   Table S1: Summary statistics Figure 3 ) (Excel file) Figures 1 and 3) . (Excel file)
Extended experimental procedures
Immunophenotyping Peripheral blood mononuclear cell isolation and staining Blood was collected in 10 ml BD Vacutainer® spray-coated K2EDTA tubes. Fresh peripheral blood cells were counted using a Coulter Ac-T Diff® cell counter (Beckman Coulter, Brea, USA) that was calibrated daily. The absolute number of white blood cells (WBC) per ml of blood determined by the cell counter was used to calculate the absolute numbers of CD45+WBC cell subsets as measured by flow cytometry. As an example, WBC 8x10 6 /ml blood represents the CD45+ WBC as identified by flow cytometry, 5% CD14+ monocytes represent 0.4x10 6 CD14+ monocytes/blood. Both erythrocyte-lysed whole blood samples (panel 1-3) and density gradient isolated PBMC (panel 4) were analyzed by flow cytometry.
Cell Processing (whole blood and PBMC) 1.5 ml whole blood was incubated in lysis buffer containing 3.0 M NH 4 Cl, 0.2 M KHCO 3 and 2mM Na 4 EDTA for 10 min to lyse erythrocytes. Remaining white blood cells were further diluted with 25 ml PBS (Braun, Melsungen, Germany) and spun down at 452 x g for 5 min at room temperature (RT). Cells were washed and spun down in PBS (Braun) once again and resuspended in 300 µl of PBS + 0.2% BSA (Sigma-Aldrich, Zwijndrecht, Netherlands). 100 µl was transferred for surface staining to each of 3 wells of a 96 well v-bottom plate (Greiner Bio-One, Frickenhausen, Germany). For PBMC isolation 8.5 ml of whole blood was placed on top of a density gradient layer (Lymphoprep TM , AxisShield, Oslo, Norway) and centrifuged at 804 x g for 20 minutes at RT, no brake. Interphase containing purified PBMC was transferred to a new tube and washed twice with PBS at 452 x g for 5 minutes. Cells were resuspended in PBS and cell count was performed. For staining 0.5 x 10 6 cells were transferred to 1 well of a 96 well v-bottom plate. Table S3 shows the fluorochrome conjugate and clone identity of the antibodies that were used in the antibody panels. Immunofluorescence reagents used to generate the panel master mixes were purchased from Beckman Coulter (Marseille, France), Becton Dickinson (San Jose, USA), eBioscience (Vienna, Austria) or BioLegend (San Diego, USA). All reagents were titrated and tested before they were used in the current study.
Reagents

Staining
All cells were surface stained in 25 µl of surface staining master mix at RT for 20 minutes. Cells were washed twice by adding PBS + 0.2% BSA and centrifuged at 250 x g for 2.5 min. Buffer was removed by flicking the plates. Before acquisition, whole blood derived cells were resuspended in 100 µl PBS + 0.2% BSA. For intracellular staining, the surface stained PBMC were fixed and permeabilized using Fix/Perm solution (eBioscience, Vienna, Austria). After 30 minutes at 4 o C protected from light, cells were washed and centrifuged at 250 x g for 2.5 min twice using permeabilisation buffer (eBioscience, Vienna, Austria). Then, 25 µl of intracellular staining master mix was applied and the samples were incubated for 30 minutes at 4 o C protected from light. After a second washing step using permeabilisation buffer, cells were resuspended in 100 µl PBS + 0.2% BSA for data acquisition.
Gating strategy
Each sample was analyzed by four 10-color antibody panels: 1. general, 2. T cell, 3. B cell and 4. intracellular T cell/Treg. Gating strategy and example stainings are illustrated in Figure S6 and S7. For every panel, the single cells within the leukocyte (CD45+) population were first gated and thereafter the major myeloid or lymphoid lineages identified. Single cells were identified by plotting the FS Time Of Flight (FS TOF) against FS. Given that single leukocytes need a well defined period of time to pass the laser, this parameter can be used to identify single cells. The first 178 out of 516 samples included did not include the TOF parameter. In these samples the leukocyte population was gated on the CD45+ leucocytes. In panel 1, granulocytes and lymphocytes were discriminated by forward scatter and side scatter, while monocytes were characterized by CD14 expression. Within the lymphocytes, T cells (CD3+, CD56-), NK cells (CD3-, CD56+), CD3+ CD56+ T cells and B cells (CD19+, HLA-DR+) were characterized. Subpopulations within T cells, NK cells and monocytes were analyzed by CD4 and CD8, CD56 and CD16, and CD14 and CD16 expression, respectively. In panel 2, CD4+ regulatory T cells (Treg, CD4+, CD25+ CD127 low) and CD45RA/CD27 and CD45RO/CD27 maturation stages of CD4 and CD8 T cells were identified. Panel 3 aimed to define CD19+ B cell maturation stages by the expression of IgM/IgD and/or CD24/CD38 expression as proposed previously (Berkowska et al., 2011; Wehr et al., 2008) . B cell subsets were additionally identified by differential CD19/CD20 and IgD/CD5 expression. Although it may identify redundant B cell populations, we decided to use different multiple gating strategies to cover most of the B cell subpopulations that have been described. In panel 4, the major T cell populations (CD4, CD8 and Treg) were identified and subsequently analyzed for proliferation status by intracellular Ki67 expression. Treg (CD4+, CD25+ CD127low FOXP3+) were analyzed for expression of CD45RA and HLA-DR. Absolute cell counts in panel 4 (PBMC obtained after density gradient isolation) were calculated as described above taking into account the whole blood cell counts minus the granulocyte number as determined in panel 1. Variability in the median fluorescence intensity of the immune markers during the 1.5 year acquisition period was low (%CV of all markers ranges from 0.15-0.38, %CV for CD16 = 0.53). In case of a limited number of specimens the pre-defined gate setting was slightly modified as biological variation sometimes seems to influence forward and side scatter (FSC and SSC, resp.) . In a minor number of specimens biological variation led to altered expression of lineage markers (e.g. CD56/CD3). In these cases, the marker settings were adjusted. We did not observe significant batch effect association of age and sex when testing against the month of collection (data not shown).
Flow cytometry measurements and data analysis
Data were acquired with a Navios Flow Cytometer as described above. Each sample suspended in 100 µl was measured for 60 seconds representing 75% of the sample volume. This prevented the intake of air leading to a nonspecific signal at the end of measurement. For the flow cytometry analysis a manual gating strategy was conducted. Each analysis was verified by two independent specialists to prevent gating errors. Analysed data was stored batch wise per 20 samples each. The statistics were exported batch wise for further analysis. 
Serum Immunoglobulin levels
Serum hormone levels
Free Thyroxin (FT4 gen II) and TSH were analysed on a Modular E170 random access analyzer (Roche Diagnostics, Mannheim).
Vitamin D measurements
25-hydroxy vitamin D3 (25OH-vitamin D3) was analysed by liquid chromatography-tandem mass spectrometry after protein precipitation and solid-phase extraction. Internal standard [ 2 H3] 25OH-vitamin D 3 (Bioconnect) was added to 100 µL serum. 50 µL NaOH (2M) was added to release protein-bound 25OH-vitamin D 3 and 500 µL Acetonitrile/Methanol (9:1) was subsequently added for protein precipitation. 700 µL H 2 O was added to 400 µL supernatant followed by solid phase extraction (Oasis HLB 1cc, Waters). Columns were conditioned with 1 mL methanol/isopropanol (95:5) and subsequently washed with 1 mL H 2 O. After application of the sample, columns were washed with 1 mL H 2 O and 1 mL methanol/H 2 O (60:40). The eluate (300 µL methanol/isopropanol 95:5) was diluted with H 2 O (3:1) and injected (10 µL) into an Agilent Technologies 1290 Infinity VL ultra high performance liquid chromatography-system (Agilent Technologies, Santa Clara, CA) equipped with a BEH C18 (1.7µm 2.1 X 50mm) analytical column (Waters Corp.) Recovery was between 90-109%. The within-run and between-run CV was 6.4% and 6.1% at 23 nmol/L and 5.1% and 5.5% at 81 nmol/L, as assessed by adapted CLSI EP5 protocol. LOQ was 7 nM (10% CV). ]-progesterone (CDN isotopes) was added to 100 µL serum. Subsequently, 300 µL Acetonitrile + 0.1% formic acid was added for protein precipitation. 300 µL H 2 O was added to 200 µL supernatant followed by solid phase extraction (Oasis HLB 1cc, Waters). Columns were pre-equilibrated with 1 mL methanol:isopropanol (95:5) and subsequently washed with 1 mL H 2 O. After application of the sample, columns were washed with 1 mL H 2 O and 1 mL methanol/H 2 O (30:70). The 300 µL eluate (methanol/isopropanol 95:5) was dried under a stream of N 2 gas, reconstituted in methanol:water (30:70) and injected (10 µL) into an Agilent Technologies 1290 Infinity VL ultra high performance liquid chromatographysystem (Agilent Technologies, Santa Clara, CA) equipped with a BEH C18 (1.7µm 2.1 X 50 mm) analytical column (Waters Corp.) at 60°C. Mobile phase A (methanol:water 20:80 + 2 mM NH 4 CH 3 COO + 0.1% formic acid) and B (methanol:water 98:2 + 2 mM NH 4 CH 3 COO + 0.1% formic acid) were run in a gradient (0.4 mL/min). The gradient program was as follows: Start gradient 70:30 A:B for 2.5 min; then to 40:60 A:B in 3.5 min; followed by a gradient in 0.5 min to 2:98 to remain such for 0.5 min; and thereafter to 70:30 A:B in 0.5 min and remain such for 0.5 min. Retention time was 1.6 (cortisol), 2.8 (11-deoxycortisol), 4.4 (testosterone), 4.9 (17-hydroxyprogesterone) and 6.1 (progesterone) min with a total run time of 8 minutes. A 9-point calibration curve was used (cortisol, testosterone, ; progesterone (Sigma)). An Agilent 6490 tandem mass spectrometer (Agilent Technologies) was operated in the electrospray positive ion mode, with a capillary voltage 3.5 kV, fragmentor voltage 380 V, sheath gas temperature 350°C and gas temperature 150 °C with N 2 collision gas. Two transitions (qualitative and quantitative) were monitored. Within-run and between-run CV was assessed by adapted CLSI EP5 protocol. For cortisol within-run and between-run CV is 3.0% and 4.0% at 303 nmol/L and 2.5% and 3.4% at 1087 nmol/L. For 11-deoxycortisol, within-run and between-run CV is 4.8% and 6.6% at 2.1 nmol/L and 4.1% and 5.9% at 25.6 nmol/L. For 17-hydroxyprogesterone, within-run and between-run CV was 5.9% and 6.1% at 2.5 nmol/L and 4.9% and 5.1% at 91 nmol/L. For testosterone, within-run and between-run CV was 4.1% and 6.0% at 0.9 nmol/L and 3.3% and 5.3 at 19 nmol/L. For progesterone, within-run and between-run CV is 2.8% and 5.1% at 4.9 nmol/L and 3.4% and 6.1 at 28 nmol/L. LOQ was 0.10 nmol/L (10% CV), 0.10 nmol/ L (10% CV), 0.05 nmol/L (15% CV) and 0.25 nmol/ L (15% CV) for 11-deoxycortisol, 17-hydroxyprogesterone, testosterone and progesterone, respectively.
Steroid hormone measurements
Statistical analysis
To test for association of cell counts or Ig levels with age, we normalized the immune traits as described above, then corrected for the effects of gender and season using a linear model. Using Spearman correlation analysis, we ascertained the significance and direction of the correlations. Significance was declared after controlling for multiple testing (FDR ≤ 0.05). To test whether gender had any effect on the inter-individual variation of the immune traits, we used the cell counts normalized using an IRT and the log2 Igs levels, after correcting for the effect of age and season using a linear model. A paired T-test between the gender-stratified samples was carried out. Significance was declared after correcting for multiple testing (FDR ≤ 0.05). To investigate the effect of season on the immune traits measured; we also made use of the IRT cell counts and log2 Igs levels. A cosinor model was fitted with the day of the year, in a one-year cycle period, using sex and age as covariates. The fitted model was compared with a reduced model without the season information and significance was ascertained (multiple correction testing; FDR ≤ 0.05) using a variance test between the full model (with season information) and the incomplete model (Dopico et al., 2015) .
